市场调查报告书
商品编码
1466483
生物保存市场:按产品、生物样本、应用和最终用户 - 全球预测 2024-2030Biopreservation Market by Product (Biopreservation Media, Equipment, Lab Information Management Systems), Biospecimens (Cells, Microorganisms, Organs), Application, End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年生物防腐市场规模为87亿美元,预计2024年将达98.9亿美元,2030年将达214.9亿美元,复合年增长率为13.79%。
生物保存是一种透过在低温下稳定其代谢活性来保存细胞、组织和器官等生物材料的过程。它在医学、农业、生物多样性保护等各个领域中发挥着重要作用。生物保存的重要性在于其能够长期维持生物样本的功能和完整性,从而促进研究工作、改善再生医学的临床结果并保护遗传资源。然而,建立和维护专门的生物保存设施成本高昂,阻碍了小型最终用户设施的快速实施。此外,处理敏感生物材料需要训练有素的人员,这进一步增加了这些资源管理的复杂性。市场相关人员正在努力透过推动冷冻保存、玻璃化和低温保存来实施具有成本效益的生物保存方法。毒性降低的新型冷冻保护剂(CPA)的开发显着提高了保存过程的效率。持续的进步旨在克服固有的限制并提高保护方法的效率,以确保研究、临床应用和生物多样性保育工作取得最佳结果。
主要市场统计 | |
---|---|
基准年[2023] | 87亿美元 |
预测年份 [2024] | 98.9亿美元 |
预测年份 [2030] | 214.9亿美元 |
复合年增长率(%) | 13.79% |
越来越多地采用冷冻作为生物保存的首选技术
冷冻保存是一种生物保存技术,涉及在极低的温度下冷冻生物样品,例如细胞、组织或整个生物体。这种方法通常用于保存精子、卵子、胚胎和其他细胞以进行研究。化学保存使用化学物质来阻止生物样本劣化或变质。此方法广泛应用于组织学、病理学和电子显微镜中製备用于显微镜检查的组织样本。
推出新型生物储存设备,提升产品功能与可靠性
生物保存介质的配製可提高细胞、组织和器官等生物样本的活力和稳定性。这些介质含有冷冻保护剂和抗氧化剂等多种成分,可保护生物检体在冷冻、解冻和储存过程中免受损坏。生物保存设备包括用于保存生物标本的各种专用设备和仪器。包括超低温冷冻柜、反应器、样本储存系统、培养箱等。 LIMS 在维护样品可追溯性和确保资料完整性方面发挥关键作用。 LIMS 帮助研究人员和实验室人员有效编目、追踪和检索样本。
增强生物样本保存功能,保护细胞和组织讯息
微生物(包括细菌、真菌和病毒)的生物保存需要冷冻或冷冻干燥以保持研究应用的活力。从各种来源(包括人类、动物和植物组织)收穫的细胞可以储存用于研究、移植和治疗。保存心臟、肾臟和肝臟等整个器官对于移植至关重要。器官的生物保存包括冷冻保存和灌注技术,以延长移植前的寿命。
应用:临床试验期间生物保存活动的潜力
生物银行储存生物样本用于研究、诊断和未来研究。临床试验保持生物样本的完整性以获得准确的测试结果,药物发现保留细胞株和组织以筛检潜在的候选药物。再生医学涉及保存干细胞和组织以进行移植和再生治疗。治疗药物需要生物保存,以确保生物药品在储存和运输过程中的稳定性。
最终用户:全球基因库生物保存活动的新需求
生物保存服务于各种最终用户,包括储存用于研究的遗传物质的基因库。生物样本库用于储存用于研究活动的医学样本。医院透过保存用于移植的组织和器官来帮助治疗患者。
区域洞察
再生医学的进步、生命科学研究投资的增加以及个人化医疗意识的不断增强正在推动美洲(尤其是北美)的生物保存产业的发展。由于强大的医疗基础设施和主要市场参与者的存在,美国和加拿大的市场正在成长。由于製药业的蓬勃发展和政府对生物研究活动的支持不断增加,亚洲生物保存市场正在迅速扩大。中国、印度、韩国和日本等国家正大力投资干细胞研究和开发,增加了对生物保存解决方案的需求。欧洲生物保存市场主要受到生命科学研究和发展以及个人化医疗计划资金增加的推动。欧盟(EU)大力投资创新药物计画(IMI)等计划,旨在加速开发更安全、更有效的治疗方法。生物样本库在欧洲也被广泛应用,许多国家都建立了国家生物样本库。
FPNV定位矩阵
FPNV定位矩阵对于评估生物保存市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对生物保存市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4. 竞争评估和情报:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1.生物防腐市场的市场规模与预测是多少?
2.生物保存市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些?
3.生物保存市场的技术趋势和法规结构是什么?
4.生物防腐市场主要厂商的市场占有率是多少?
5. 进入生物防腐市场的适当型态和策略手段是什么?
[192 Pages Report] The Biopreservation Market size was estimated at USD 8.70 billion in 2023 and expected to reach USD 9.89 billion in 2024, at a CAGR 13.79% to reach USD 21.49 billion by 2030.
Biopreservation is the process of preserving biological materials, such as cells, tissues, and organs, by stabilizing their metabolic activity at reduced temperatures. It plays a crucial role in various fields like medicine, agriculture, and biodiversity conservation. The significance of biopreservation lies in its ability to maintain the function and integrity of biological samples for extended periods, thereby facilitating research efforts, improving clinical outcomes in regenerative medicine, and conserving genetic resources. However, establishing and maintaining specialized facilities for biopreservation can be expensive, impeding their fast adoption in small-scale end-user facilities. Moreover, the need for trained personnel to handle sensitive biological materials adds an additional layer of complexity to managing these resources. Market players are working on introducing cost-effective biopreservation methods by advancing cryopreservation, vitrification, and hypothermic storage. The development of new cryoprotective agents (CPAs) with reduced toxicity has significantly improved the efficiency of preservation processes. Ongoing advancements are aimed at overcoming inherent limitations and enhancing the efficiency of preservation methods to ensure optimal outcomes in research, clinical applications, and biodiversity conservation efforts.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 8.70 billion |
Estimated Year [2024] | USD 9.89 billion |
Forecast Year [2030] | USD 21.49 billion |
CAGR (%) | 13.79% |
Type: Increasing adoption of cryopreservation as a preferred technique of biopreservation
Cryopreservation is a biopreservation technique that involves freezing biological samples, such as cells, tissues, or even whole organisms, at extremely low temperatures. This method is commonly used in the preservation of sperm, eggs, embryos, and other cells for research. Chemical preservation relies on the use of chemicals to arrest the degradation and decay of biological samples. This method is widely applied in histology, pathology, and electron microscopy to prepare tissue samples for examination under a microscope.
Product: Introduction of new biopreservation equipment with improved features and reliability
Biopreservation media are formulated to extend the viability and stability of biological samples, such as cells, tissues, and organs. These media contain a variety of components, including cryoprotectants and antioxidants, which protect biological material from damage during freezing, thawing, or storage. Biopreservation equipment includes a range of specialized devices and instruments used in the preservation of biological samples. It includes cryogenic freezers, bioreactors, sample storage systems, and incubators. LIMS plays an important role in maintaining sample traceability and ensuring data integrity. It helps researchers and lab personnel efficiently catalog, track, and retrieve samples.
Biospecimen: Enhanced capabilities of biopreservation to protect cell and tissue matters
Biopreservation of microorganisms, including bacteria, fungi, and viruses, involved freezing or lyophilization to maintain their viability for research applications. Cells from various sources, such as human, animal, and plant tissues, can be preserved for research, transplantation, or therapeutic use. Preserving whole organs, such as hearts, kidneys, or livers, is crucial for transplantation. Organ biopreservation includes cold storage or perfusion techniques to extend their life until they can be transplanted.
Application: Potential use of biopreservation activities during clinical trials
Biobanking involves preserving biological samples for research, diagnostics, and future studies. Clinical trials maintain the integrity of biological specimens for accurate trial results, while drug discovery includes storing cell lines and tissues for screening potential drug candidates. Regenerative medicine includes preserving stem cells and tissues for transplantation and regenerative therapies. In therapeutics, biopreservation is necessary to ensure the stability of biopharmaceuticals during storage and transport.
End-User: Emerging need for biopreservation activities among gene banks worldwide
Biopreservation serves various end-users, including gene banks, which store genetic material for research. Biobanks use it to preserve medical samples for research activities. Hospitals benefit from preserving tissues and organs for transplantation, aiding patient care.
Regional Insights
In the Americas, particularly in North America, the biopreservation industry is driven by advancements in regenerative medicine, increased investments in life sciences research, and growing awareness regarding personalized medicine. The United States and Canada observe a growing market owing to its strong healthcare infrastructure and the presence of major market players. Asia's biopreservation market is rapidly expanding due to its booming pharmaceutical industry and increasing government support towards biological research activities. Nations such as China, India, South Korea, and Japan are witnessing growing demands for biopreservation solutions as they invest heavily in stem cell research & therapy development. Europe's biopreservation market is primarily driven by a strong focus on research & development in the life sciences sector and increasing funding for personalized medicine initiatives. The European Union (EU) has been investing significantly in projects such as the Innovative Medicines Initiative (IMI) aimed at accelerating the development of safer and more effective treatments. Biobanking is also widely practiced across Europe, with many countries having established national biobanks.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Biopreservation Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biopreservation Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Biopreservation Market, highlighting leading vendors and their innovative profiles. These include Audubon Bioscience, Azenta Life Sciences, Bio-Techne Corporation, BioIVT LLC, BioLife Solutions Inc., Charles River Laboratories International, Inc., Chart Industries, Inc., Eppendorf SE, Exact Sciences Corporation, Helmer Scientific Inc., LANXESS Corporation, Lifeline Scientific Inc., Merck KGaA, MVE Biological Solutions, OPS Diagnostics, LLC, Princeton CryoTech Inc., REPROCELL Inc., Sierra Molecular Corporation, So-Low Environmental Equipment Co., STEMCELL Technologies Inc., Taylor-Wharton, Thermo Fisher Scientific Inc., ThermoGenesis Holdings, Inc., Upkara, and X-Therma Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Biopreservation Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biopreservation Market?
3. What are the technology trends and regulatory frameworks in the Biopreservation Market?
4. What is the market share of the leading vendors in the Biopreservation Market?
5. Which modes and strategic moves are suitable for entering the Biopreservation Market?